SAFETY SHOT INC (SHOT)
US48208F1057 - Common Stock
Taking everything into account, SHOT scores 1 out of 10 in our fundamental rating. SHOT was compared to 37 industry peers in the Personal Care Products industry. Both the profitability and financial health of SHOT have multiple concerns. SHOT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year SHOT has reported negative net income.
SHOT had a negative operating cash flow in the past year.
SHOT had negative earnings in each of the past 5 years.
SHOT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -349.37%, SHOT is doing worse than 94.59% of the companies in the same industry.
SHOT has a Return On Equity of -577.55%. This is amonst the worse of the industry: SHOT underperforms 89.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -349.37% | ||
| ROE | -577.55% | ||
| ROIC | N/A |
ROA(3y)-147.58%
ROA(5y)-132.61%
ROE(3y)-251.68%
ROE(5y)-228.61%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SHOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SHOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
SHOT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SHOT has been increased compared to 5 years ago.
The debt/assets ratio for SHOT has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -11.57, we must say that SHOT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -11.57, SHOT is not doing good in the industry: 97.30% of the companies in the same industry are doing better.
SHOT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.10, SHOT perfoms like the industry average, outperforming 59.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.57 |
ROIC/WACCN/A
WACC8.19%
2.3 Liquidity
SHOT has a Current Ratio of 1.76. This is a normal value and indicates that SHOT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.76, SHOT perfoms like the industry average, outperforming 45.95% of the companies in the same industry.
SHOT has a Quick Ratio of 1.55. This is a normal value and indicates that SHOT is financially healthy and should not expect problems in meeting its short term obligations.
SHOT has a better Quick ratio (1.55) than 64.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.55 |
3. Growth
3.1 Past
The earnings per share for SHOT have decreased strongly by -55.61% in the last year.
The Revenue for SHOT has decreased by -82.82% in the past year. This is quite bad
Measured over the past years, SHOT shows a very negative growth in Revenue. The Revenue has been decreasing by -42.57% on average per year.
EPS 1Y (TTM)-55.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1499.3%
Revenue 1Y (TTM)-82.82%
Revenue growth 3Y-42.57%
Revenue growth 5YN/A
Sales Q2Q%-70.03%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
SHOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SHOT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SAFETY SHOT INC
NASDAQ:SHOT (9/16/2024, 3:05:09 PM)
1.39
+0.04 (+2.96%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap72.31M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -349.37% | ||
| ROE | -577.55% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.55 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-55.61%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-82.82%
Revenue growth 3Y-42.57%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y